Do you want to read an article? Please log in or register.
Trends in the Management of Proliferative Diabetic Retinopathy in the First Year After Diagnosis
Retinal Diseases
Related content
Retinal Diseases
30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes
Diabetes Care
Calligaro LI, Liew G, Cho YH, Allen DW, Pryke A, Cusumano J, Chan A, Craig ME, Donaghue KC
doi: 10.2337/dc26-0388
Retinal Diseases
Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial
JAMA Ophthalmol
Wolf S, Chen Y, Li X, Shimura M, Sakamoto T, Wykoff CC, Emanuelli A, Salehi-Had H, Yan K, Kovacic L, Kim Y
doi: 10.1001/jamaophthalmol.2026.1008
Retinal Diseases
Peripheral retinal haemorrhage density on ultra-widefield imaging as a novel biomarker for predicting diabetic retinopathy progression: a 2-year longitudinal study in Asians
Br J Ophthalmol
Cao D, Tan R, Goh RA, Yang Q, Fleming A, Makdoom NBB, Tan TE, Ong C, Ling J, Wong TY, Tan GSW
doi: 10.1136/bjo-2025-327940
Macular Diseases
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report
BMJ Open Ophthalmol
Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K
doi: 10.1136/bmjophth-2025-002467
Retinal Diseases
Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort study
Br J Ophthalmol
Liu Y, Huang J, Ao M, Huang Y, Ma X, Han Q, Sun D, Zhong J, Qiu Q, Peng H, Wang Z, Ye J, Ma Z, Hao Y, Hu Y, Chang Q, Lu H, Li X, Liang J, Li S, Li J, Yu X, Yang L, Bi C, Li B, Zhang F, Wu R, Jin X, Zhou G, Liao M, Lei Y, Han H, Yan H
doi: 10.1136/bjo-2025-329066
Retinal DiseasesFurther Publications
Ultra-widefield color fundus images and artificial intelligence for diagnosis of diabetic retinopathy: A systematic review and meta-analysis
Retina
Hirosawa K, Inomata T, Nagino K, Sung J, Midorikawa-Inomata A, Eguchi A, Fujio K, Kobayashi H, Nakao S
doi: 10.1097/IAE.0000000000004939
COMMENTED
Retinal Diseases
Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level Synthesis
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Anson M, Iqbal A, Azmi S, Weston P, Hughes L, Choudhury M, Hughes DM, Zheng Y, Burgess PI, Alam U
doi: 10.1111/dom.71084
RECOMMENDED
Retinal Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Shah J, Makwana B, Panchal K, Patel V, Patel T, Khadke S, Verma A, Vivekanandan S, Kong Y, Upadhyay J, Dani SS, Ramsey KM, Ganatra S, Ramsey DJ
doi: 10.1016/j.ajo.2026.04.021
Retinal Diseases
Associations between fenofibrate use and sight-threatening diabetic retinopathy in type 2 diabetes: UK real-world evidence
J Clin Endocrinol Metab
Tan L, Cooper JM, Gokhale K, Sainsbury C, Denniston AK, Toulis KA, Crowe FL, Nirantharakumar K, Wang J
doi: 10.1210/clinem/dgag367